• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON ENDO-SURGERY, LLC. PROXIMATE*HCS HEMORR CIR STAPL; STAPLE, IMPLANTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON ENDO-SURGERY, LLC. PROXIMATE*HCS HEMORR CIR STAPL; STAPLE, IMPLANTABLE Back to Search Results
Catalog Number PPH01
Health Effect - Clinical Codes Hemorrhage/Blood Loss/Bleeding (1888); Itching Sensation (1943); Pain (1994); Thrombosis (2100); Blood Loss (2597); No Code Available (3191)
Date of Event 01/01/2005
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).Publication year of 2005.Batch # unk.This report is related to a journal article; therefore, no product will be returned for analysis and the manufacturing records cannot be reviewed as the lot/batch number has not been provided.(b)(4).
 
Event or Problem Description
It was reported via literature entitled: stapled hemorrhoidopexy vs.Diathermy excision for fourth-degree.Hemorrhoids: a randomized, clinical.Trial and review of the literature.Author : hector ortiz, jose marxo , pedro armendariz, mario de miguel.Citation: dis colon rectum (2005); 48: 809¿815.Doi: 10.1007/s10350-004-0861-z.The aim of this prospective study was to compare the results of stapled hemorrhoidopexy with those of conventional diathermy excision for controlling symptoms in patients with fourth-degree hemorrhoids.Between january 2001 and february 2002, 31 consecutive patients with fourth-degree hemorrhoids were enrolled in the study.The patients were randomized into two groups: 15 patients (8 male and 7 female; mean age: 47 years; age range: 28-69 years) underwent stapled hemorrhoidopexy and 16 patients (11 male and 5 female; mean age: 49 years; age range: 32-69 years) underwent diathermy excision.In stapled hemorrhoidopexy, the stapling procedure was performed according to the technique described by longo.The pph01 stapling gun (ethicon) was opened to its maximum position and introduced through the anus.A pursestring suture was tied on the stapler shaft, and the head of the instrument was closed on the anvil, incorporating the mucosal and submucosal tissue in the pursestring suture in the head of the gun.The stapler was then fired and gently withdrawn.Reported complications included minor staple-line bleeding (n-11) in which patients required hemostatic sutures, external hemorrhoidal thrombosis (n-1) which required medical treatment, fecal impaction (n-1) which required medical treatment, pain during the first 14 days (n-?), recurrent prolapse (n-8) in which 5 patients responded well to a later conventional diathermy hemorrhoidectomy, persistence of itching (n-6), tenesmus (n-6), hemorrhage (n-1), skin tags (n-10) and urgency (n-2).In conclusion, stapled hemorrhoidopexy was not effective as a definitive cure for the symptoms of prolapse and itching in patients with fourth-degree hemorrhoids.The conventional diathermy hemorrhoidectomy should continue to be recommended in patients with symptomatic, prolapsed, irreducible piles.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Common Device Name
STAPLE, IMPLANTABLE
Manufacturer (Section D)
ETHICON ENDO-SURGERY, LLC.
475 calle c
guaynabo 00969
MDR Report Key8845188
Report Number3005075853-2019-20912
Device Sequence Number19364963
Product Code GDW
UDI-Device Identifier10705036012993
UDI-Public10705036012993
Combination Product (Y/N)N
PMA/510(K) Number
K030925
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,literature
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 07/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberPPH01
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 07/11/2019
Initial Report FDA Received Date07/31/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-